- Country: Czech Republic
- Summary: Euspa/Op/07/2024 - Complementary Health Insurance
- CZT Ref No: 103835280
- Deadline: 17 Jul 2024
- Financier: European Union Agency for the Space Programme (EUSPA)
- Purchaser Ownership: Government
- Tender Value: EUR 1322000
- Notice Type: Tender
- Document Ref. No.: 405485-2024
- Purchaser's Detail:Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details.
- Description:
- The objective of this procurement is the provision, for the benefit of EUSPA staff members (and their family members), of an insurance coverage topping up the existing health and hospitalisation insurance, as set out in the Staff Regulations [the so-called Joint Sickness Insurance Scheme of the European Union], so as to provide reimbursement up to 100% of health and hospitalisation expenses partially covered by JSIS.
Doc Title: EUSPA/OP/07/2024 - Complementary Health Insurance
Contract Type: services - Documents:
If you are registered member, kindly login to view full details of this tender notice:
CLICK HERE TO LOGINEuspa/Op/07/2024 - Complementary Health Insurance - Czech Tender
The EUROPEAN UNION AGENCY FOR THE SPACE PROGRAMME, a Government sector organization in Czech Republic, has announced a new tender for Euspa/Op/07/2024 - Complementary Health Insurance. This tender is published on CzechTenders under CZT Ref No: 103835280 and is categorized as a Tender. Interested and eligible suppliers are invited to participate by reviewing the tender documents and submitting their bids before the deadline on 2024-07-17.
The estimated tender value is EUR 1322000, and full details, including technical specifications and submission requirements, are provided in the official tender documents. Ensure all submissions meet the criteria outlined to be considered for evaluation.
